• CSRP3 Gene Mutation Analysis
  • Treponema pallidum Antibody by TP-PA, Serum
  • Psychosis, unspecified
  • Haptoglobin
  • Lipoprotein Associated Phospholipase A2 Activity
  • Peripheral Myelin Protein 22 (PMP22), Peripheral Neuropathy, FISH
  • Flecainide, Serum
  • Lactoferrin, Fecal
  • OvaWatch, Multiplex Biomarker for Ovarian cancer Risk Assessment
  • Anti-IgE Antibody
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Brugada Syndrome Multi-Gene Panel, NGS
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Brugada Syndrome Multi-Gene Panel, NGS
Medical Test

Interpretation
Access to Brugada Syndrome Multi-Gene Panel, NGS is restricted.